Guidelines - Page 5 of 17 Posts on Medivizor
Navigation Menu

Guidelines Posts on Medivizor

Imaging and Biopsy After Mastectomy

Posted by on Oct 5, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to determine how many patients were going for imaging and biopsy after their mastectomy following breast cancer diagnosis. The study found that between 10-15% of patients underwent imaging after mastectomy, and 6-8% underwent biopsy, and in a small number of these cases, remaining cancer cells were...

Read More

Breast Reconstruction Following Breast Cancer Treatment

Breast Reconstruction Following Breast Cancer Treatment

Posted by on Oct 5, 2018 in Breast cancer | 0 comments

In a nutshell This is a 2018 update on breast reconstruction following breast cancer treatment. It has been found that nearly 40% of women who undergo a mastectomy will have a breast reconstruction. Some background It was estimated that in 2017 106000 reconstructive breast surgeries were done. The main reason for this is to do with the psychological...

Read More

2018 recommendations for the treatment of localized prostate cancer: Part II

2018 recommendations for the treatment of localized prostate cancer: Part II

Posted by on Sep 25, 2018 in Prostate cancer | 0 comments

In a nutshell This article reviewed treatment guidelines that have been recommended for patients with early-stage prostate cancer. Some background This analysis of existing treatment guidelines was done by the leading experts in prostate cancer research. They have made recommendations on the treatment of early-stage prostate cancer.  Methods...

Read More

Managing hypertension: recommendations from the experts

Posted by on Sep 21, 2018 in Hypertension | 0 comments

In a nutshell This study reviewed data on the management of hypertension and made recommendations. Some background Hypertension (high blood pressure) is a common condition that requires strict blood pressure (BP) control. Uncontrolled hypertension can lead to heart disease, stroke, and death. Hypertension can be treated using medication or by...

Read More

Is pembrolizumab better than the standard of care in unresponsive Hodgkin’s Lymphoma?

Is pembrolizumab better than the standard of care in unresponsive Hodgkin’s Lymphoma?

Posted by on Jun 11, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated if pembrolizumab (Keytruda) was more effective than the standard of care in Hodgkin's lymphoma patients unresponsive to brentuximab vedotin (Adcetris). The main finding was that pembrolizumab was more effective than the standard of care in these patients Some background Hodgkin's Lymphoma is...

Read More

Update on guidelines from the International Workshop on Chronic Lymphocytic Leukemia

Update on guidelines from the International Workshop on Chronic Lymphocytic Leukemia

Posted by on May 4, 2018 in Leukemia | 0 comments

In a nutshell This study reviewed updated guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia. Some background In 2008, the International Workshop on CLL (iwCLL) published guidelines for clinical trials for chronic lymphocytic leukemia (CLL) patients. These guidelines were...

Read More